InsiderClue
← All stocks

Natera, Inc.

NTRA Scheduled selling only
CIK 0001604821 #586 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$57.66M
$57.66M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 40 sales
Net
−$57.66M
$0.00 against sales at will

By person

17 insiders · 40 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
—
$51.20M (35) scheduled
−$51.20M
2,127,394
1.48%
$744.60M
−12.5%
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
—
$5.92M (4) scheduled
−$5.92M
110,859
0.0769%
$38.80M
−1.4%
Chapman Steven Leonard
CEO AND PRESIDENT
—
$545.04K (1) scheduled
−$545.04K
459,452
0.3187%
$160.81M
−17.5%
BOTHA ROELOF
Director
—
—
—
1,080,783
0.7498%
$378.28M
−17.9%
Sheena Jonathan
Director
—
—
—
295,274
0.2048%
$103.35M
−34.9%
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
—
—
—
197,257
0.1368%
$69.04M
+72.1%
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
—
—
—
170,073
0.1180%
$59.53M
−17.6%
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
—
—
—
51,637
0.0358%
$18.07M
−28.2%
HEALY JAMES
Director
—
—
—
46,260
0.0321%
$16.19M
+0.9%
Baynes Roy D.
Director
—
—
—
20,158
0.0140%
$7.06M
+28.5%
Marcus Gail Boxer
Director
—
—
—
7,852
0.0054%
$2.75M
−63.6%
Bertagnolli Monica
Director
—
—
—
7,020
0.0049%
$2.46M
—
ROSENMAN HERM
Director
—
—
—
5,927
0.0041%
$2.07M
−91.0%
Williams Brinkley Ruth
Director
—
—
—
5,475
0.0038%
$1.92M
+84.7%
Chapman Rowan E
Director
—
—
—
4,663
0.0032%
$1.63M
−41.5%
Rubin Eric H
Director
—
—
—
2,204
0.0015%
$771.42K
—
Lynch Thomas J. Jr.
Director
—
—
—
1,905
0.0013%
$666.76K
—

Individual transactions

40
Insider
Date
Role
Action
Shares
Price
Amount
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan indirect
2,000
$350.01
$700.01K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
800
$351.25
$281.00K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
14,500
$350.81
$5.09M
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
4,206
$349.51
$1.47M
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
8,094
$348.65
$2.82M
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,700
$347.81
$939.09K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,122
$346.68
$388.97K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,700
$345.38
$932.53K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
5,839
$344.49
$2.01M
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,240
$343.56
$769.58K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,956
$342.18
$669.30K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,813
$341.41
$618.97K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,549
$340.25
$867.29K
Rabinowitz Matthew
15 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,481
$339.24
$502.41K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
4,064
$342.51
$1.39M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,700
$341.35
$921.64K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,000
$340.31
$680.63K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,100
$339.37
$712.67K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,400
$338.30
$473.61K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,207
$337.17
$744.13K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
8,459
$336.27
$2.84M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
3,754
$335.18
$1.26M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,818
$334.24
$941.88K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
2,246
$333.07
$748.07K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,000
$332.02
$332.02K
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
3,494
$330.98
$1.16M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
6,206
$330.05
$2.05M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
6,015
$329.12
$1.98M
Rabinowitz Matthew
14 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,537
$328.09
$504.28K
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
1,300
$329.62
$428.51K
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
15,764
$328.95
$5.19M
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
17,933
$327.97
$5.88M
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
10,556
$327.14
$3.45M
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
3,647
$326.11
$1.19M
Rabinowitz Matthew
11 Sep 2026
EXECUTIVE CHAIRMAN
Sold on a plan
800
$325.01
$260.01K
Moshkevich Solomon
2 Sep 2026
PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
15,160
$326.89
$4.96M
Chapman Steven Leonard
1 Sep 2026
CEO AND PRESIDENT
Sold on a plan
1,698
$320.99
$545.04K
Moshkevich Solomon
1 Sep 2026
PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
600
$321.91
$193.14K
Moshkevich Solomon
1 Sep 2026
PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
1,400
$320.92
$449.29K
Moshkevich Solomon
1 Sep 2026
PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
1,000
$319.76
$319.76K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 40
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 7 Sep 2016